首页> 外国专利> FC RECEPTOR-MEDIATED DRUG DELIVERY

FC RECEPTOR-MEDIATED DRUG DELIVERY

机译:FC受体介导的药物交付

摘要

Provided are methods and compositions for modulating an immune response or for treating a disease or condition in a subject, such as cancer, infection, autoimmune disease, allergy, and asthma. The methods involve systemically administering to a subject a particle comprising a surface and an interior, wherein the surface of the particle comprises an antigen, the interior of the particle comprises an immune modulating agent, and the subject is or has been primed to mount an antibody response to the antigen. The antibody response to the particle permits Fc receptor-bearing target cells to take up the particle, thereby delivering the immune modulating agent to the target cells and modulating an immune response of the subject. In various embodiments, the immune modulating agent can be selected from the group consisting of therapeutic agents, immune activators, and immune suppressors. In certain embodiments, the immune activator is a TLR agonist, e.g, a CpG oligodeoxynucleotide.
机译:提供了用于调节免疫应答或用于治疗受试者的疾病或病症例如癌症,感染,自身免疫疾病,变态反应和哮喘的方法和组合物。所述方法包括向受试者全身性地施用包含表面和内部的颗粒,其中所述颗粒的表面包含抗原,所述颗粒的内部包含免疫调节剂,并且所述受试者已经或已经被引发以安装抗体。对抗原的反应。对颗粒的抗体应答允许携带Fc受体的靶细胞摄取该颗粒,从而将免疫调节剂递送至靶细胞并调节受试者的免疫应答。在各种实施方案中,免疫调节剂可以选自治疗剂,免疫活化剂和免疫抑制剂。在某些实施方案中,免疫活化剂是TLR激动剂,例如CpG寡聚脱氧核苷酸。

著录项

  • 公开/公告号EP3436066A1

    专利类型

  • 公开/公告日2019-02-06

    原文格式PDF

  • 申请/专利权人 CHECKMATE PHARMACEUTICALS INC.;

    申请/专利号EP20170719072

  • 发明设计人 KRIEG ARTHUR M.;

    申请日2017-03-31

  • 分类号A61K39/395;C12N15/117;

  • 国家 EP

  • 入库时间 2022-08-21 12:25:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号